Antifungal Agents Market Industry Trends, Segmentation, Sales Revenue by 2027

1
Rise in Prevalence of Fungal Infections,
Acceleration in RD Activities, Favorable
Government Initiatives Create Headways for
Antifungal Agents Market Sophistication In the
coming years, the worldwide antifungal agents
market is projected to grow at a promising pace
owing to the rising incidence of nosocomial
infections. Fungi are microorganisms that are
capable of causing various infections in humans,
spanning from superficial skin to systematic that
enter the body through inhalation. Lower immune
systems and exposure to unhygienic conditions
are root causes for the occurrence of infections
in human bodies. Primarily, the market is driven
by a rise in people suffering from fungal
infections on hair, skin, and lungs. Get a
Sample Copy of Antifungal Agents Market
https//www.fairfieldmarketresearch.com/report/ant
ifungal-agents-market/request-sample In the wake
of the pandemic, the world witnessed disruptions
in supply chains. To overcome this supply chain
turmoil, governments have taken diverse
initiatives. Besides, growing research and
development activities coupled with a pipeline of
new drugs are set to expand the antifungal
agents market exponentially. Going forward, the
market growth is further augmented by the
greater use of antimicrobial drugs in developing
economies, rising awareness of several fungal
infections, and a growing number of
over-the-counter antiretroviral (OTC)
drugs. Azoles Gains Supremacy Over the Other
Types of Antifungal Agents Over the recent past,
the antifungal agents market has been witnessing
an upward trend. Based on the type of drug, the
market is fragmented as azoles, polyenes,
allylamines, and echinocandins. Among these
types, considering the capability to generate
higher revenue and fungicidal properties, the
azoles are envisaged to reign supreme across the
types of antifungal agents. Synthetic azoles and
semi-synthetic compounds are extensively used to
treat infections along with fungal infections,
thereby upscaling the market. Additionally,
several therapeutic drugs viz Cresemba,
Diflucan, Noxafil, and Vfend of azoles drug class
are projected to contribute significantly
towards the antifungal agents market valuation.
Azoles' ability to work on a broader range of
fungal infections with improved safety levels has
gained it excellent prominence and increased its
sales.
2
North America is Growing Leaps and Bounds at the
Helm of Soaring RD Activities and Presence of
Well-Established Players North America
successfully dominates the antifungal agents
market by garnering a lions share over the
forecast timeline. A sophisticated approval
process framework, surging research and
development activities, and the growing
prevalence of staunch players are building the
momentum for regional market growth. In the
coming years, the usage of these antifungal
agents is anticipated to rise in the developed
countries of North America. Based on analysis,
the U.S. and Canada are expected to steer the
market at the helm of increasing sales of
antifungal agents due to escalating rates of
fungal infections. The higher susceptibility of
the countrys population to chronic diseases
affects the immune system, thus, causing fungal
infections. The consistent incidence and
mortality closely related to fungal infections
increased the demand for antifungal agents in the
region, and created lucrative opportunities for
pharmacists to develop effective novel and
anti-fungal novels. Key Players are
Progressively Developing Advanced Effective
Products to Enhance their Market
Positions Competitive players across the global
antifungal agents market include Abbott
Laboratories, Glenmark, Bayer AG, Merck Co.
Inc., Novartis, and Pfizer, GlaxoSmithKline. The
major players are progressively increasing their
research and development activities to develop
next-gen antifungal agents that can efficiently
fight fungal infections. For instance In 2021,
Scynexis came up with a new antifungal drug to
treat vaginal yeast infections, Brexafemme, which
got approved by the US FDA (Food and Drug
Administration). Check Complete Report Details
of market _at_ https//www.fairfieldmarketresearch.c
om/report/antifungal-agents-market About
Us Fairfield Market Research is a UK-based
market research provider. Fairfield offers a wide
spectrum of services, ranging from customized
reports to consulting solutions. With a strong
European footprint, Fairfield operates globally
and helps businesses navigate through business
cycles, with quick responses and multi-pronged
approaches. The company values an eye for
insightful take on global matters, ably backed by
a team of exceptionally experienced researchers.
With a strong repository of syndicated market
research reports that are continuously published
updated to ensure the ever-changing needs of
customers are met with absolute promptness.
3
Contact Fairfield Market Research London, UK UK
44 (0)20 30025888 USA 1 (844) 3829746
(Toll-free) Web https//www.fairfieldmarketresear
ch.com/ Email sales_at_fairfieldmarketresearch.com F
ollow Us LinkedIn